From October 1, 2022 to December 31, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 5,260,910 shares, representing 0.9% for CNY 243.27 million under the buyback announced on March 19, 2022.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.55 CNY | +0.35% | -1.62% | -9.58% |
May. 21 | Autobio Diagnostics' Unit Gets Nod for Two Products | MT |
Apr. 19 | Autobio Diagnostics' Q1 Profit Jumps 34% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.58% | 4.13B | |
-4.92% | 12.27B | |
-5.82% | 7.99B | |
+5.43% | 5.69B | |
+26.16% | 5.42B | |
-59.63% | 2.7B | |
+8.44% | 2.6B | |
-3.70% | 2.38B | |
+21.00% | 2.1B | |
-7.49% | 1.8B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.